148 related articles for article (PubMed ID: 8804132)
1. Association study between schizophrenia and monoamine oxidase A and B DNA polymorphisms.
Coron B; Campion D; Thibaut F; Dollfus S; Preterre P; Langlois S; Vasse T; Moreau V; Martin C; Charbonnier F; Laurent C; Mallet J; Petit M; Frebourg T
Psychiatry Res; 1996 Jun; 62(3):221-6. PubMed ID: 8804132
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase and agitation in psychiatric patients.
Nikolac Perkovic M; Svob Strac D; Nedic Erjavec G; Uzun S; Podobnik J; Kozumplik O; Vlatkovic S; Pivac N
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():131-46. PubMed ID: 26851573
[TBL] [Abstract][Full Text] [Related]
3. The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia.
Madzarac Z; Tudor L; Sagud M; Nedic Erjavec G; Mihaljevic Peles A; Pivac N
Curr Issues Mol Biol; 2021 Jul; 43(2):618-636. PubMed ID: 34287249
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidases A and B gene polymorphisms in migraine patients.
Filic V; Vladic A; Stefulj J; Cicin-Sain L; Balija M; Sucic Z; Jernej B
J Neurol Sci; 2005 Feb; 228(2):149-53. PubMed ID: 15694196
[TBL] [Abstract][Full Text] [Related]
5. A study of linkage disequilibrium between polymorphic loci for monamine oxidases A and B in schizophrenia.
Wei J; Hemmings GP
Psychiatr Genet; 1999 Dec; 9(4):177-81. PubMed ID: 10697823
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
[TBL] [Abstract][Full Text] [Related]
7. Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis.
Norton N; Kirov G; Zammit S; Jones G; Jones S; Owen R; Krawczak M; Williams NM; O'Donovan MC; Owen MJ
Am J Med Genet; 2002 Jul; 114(5):491-6. PubMed ID: 12116182
[TBL] [Abstract][Full Text] [Related]
8. Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population.
Qiu HT; Meng HQ; Song C; Xiu MH; Chen DC; Zhu FY; Wu GY; Kosten TA; Kosten TR; Zhang XY
Brain Res; 2009 Sep; 1287():67-73. PubMed ID: 19573521
[TBL] [Abstract][Full Text] [Related]
9. Association study of MAO-A and DRD4 genes in schizophrenic patients with aggressive behavior.
Fresan A; Camarena B; Apiquian R; Aguilar A; Urraca N; Nicolini H
Neuropsychobiology; 2007; 55(3-4):171-5. PubMed ID: 17657171
[TBL] [Abstract][Full Text] [Related]
10. The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men.
Pivac N; Knezevic J; Mustapic M; Dezeljin M; Muck-Seler D; Kozaric-Kovacic D; Balija M; Matijevic T; Pavelic J
Life Sci; 2006 May; 79(1):45-9. PubMed ID: 16427095
[TBL] [Abstract][Full Text] [Related]
11. Association of A/G polymorphism in intron 13 of the monoamine oxidase B gene with schizophrenia in a Spanish population.
Gassó P; Bernardo M; Mas S; Crescenti A; Garcia C; Parellada E; Lafuente A
Neuropsychobiology; 2008; 58(2):65-70. PubMed ID: 18832861
[TBL] [Abstract][Full Text] [Related]
12. [Association study of the polymorphisms of monoamine oxidase A genes with schizophrenia].
Shi YZ; Wang CH; Lv LX; Wang YH; Zhang HX; Lou BY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):457-9. PubMed ID: 17680543
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms.
Peitl V; Štefanović M; Karlović D
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():209-215. PubMed ID: 28416295
[TBL] [Abstract][Full Text] [Related]
14. Platelet monoamine oxidase activity in relation to alleles of dopamine D4 receptor and tyrosine hydroxylase genes.
Garpenstrand H; Ekblom J; Hallman J; Oreland L
Acta Psychiatr Scand; 1997 Oct; 96(4):295-300. PubMed ID: 9350959
[TBL] [Abstract][Full Text] [Related]
15. The monoamine oxidase-A gene and major psychosis in Japanese subjects.
Sasaki T; Hattori M; Sakai T; Kato T; Kunugi H; Hirose T; Nanko S
Biol Psychiatry; 1998 Nov; 44(9):922-4. PubMed ID: 9807650
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between schizophrenia and polymorphisms in dopamine metabolism and transport genes.
Alvarez S; Mas S; Gassó P; Bernardo M; Parellada E; Lafuente A
Fundam Clin Pharmacol; 2010 Dec; 24(6):741-7. PubMed ID: 20041956
[TBL] [Abstract][Full Text] [Related]
17. Poor outcome and low platelet MAO activity in chronic schizophrenia.
Bierer L; Docherty JP; Young JG; Giller E; Cohen D
Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867
[TBL] [Abstract][Full Text] [Related]
18. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
[TBL] [Abstract][Full Text] [Related]
19. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype.
Garpenstrand H; Ekblom J; Forslund K; Rylander G; Oreland L
J Neural Transm (Vienna); 2000; 107(5):523-30. PubMed ID: 11072748
[TBL] [Abstract][Full Text] [Related]
20. Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men.
Costa-Mallen P; Costa LG; Checkoway H
Neurosci Lett; 2005 Sep; 385(2):158-62. PubMed ID: 15955630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
